Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 143-149

  Hough, C J ^a   Irwin, R P ^a,c   Gao, X M ^a   Rogawski, M A ^b   Chuang, D M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FURA 2; N METHYL DEXTRO ASPARTIC ACID; PREGNENOLONE SULFATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CEREBELLUM; DRUG EFFECT; DRUG INHIBITION; EVOKED RESPONSE; GRANULE CELL; MICROFLUOROMETRY; NEUROTOXICITY; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; CALCIUM; CARBAMAZEPINE; CEREBELLUM; CYTOPLASMIC GRANULES; DRUG SYNERGISM; GLYCINE; INTRACELLULAR FLUID; N-METHYLASPARTATE; POTASSIUM CHLORIDE; PREGNENOLONE; RATS;

EID: 0029670389     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BALAZS, R., HACK, N. AND JORGENSEN, O. S.: Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci. Lett. 87: 80-86, 1988.
2. 2+ levels in neuronal culture. Eur. J. Pharmacol. 219: 53-57, 1992.
3. CEREGHINO, J. J., BROCK, J. J., VAN METER, J. C., PENRY, J. N., SMITH, L. D. AND WHITE, B. G.: Carbamazepine for epilepsy a controlled prospective evaluation. Neurology 24: 401-410, 1974.
4. 1 binding sites. Eur. J. Pharmacol. 164: 399-401, 1989.
5. 2+ uptake in cerebellar granule cell cultures mainly results from NMDA receptor activation. Eur. J. Pharmacol. 244: 57-65, 1993.
6. 2+-spikes in mammalian non-myelinated axons. Eur. J. Pharmacol. 175: 155-163, 1990.
7. FISHER, R. S. AND CYSYK, B.: A fetal overdose of carbamazepine: Case report and review of literature. J. Toxicol. Clin. Toxicol. 26: 477-486, 1988.
8. GALLO, V., KINGSBURY, A., BALAZS, R. AND JORGENSEN, O. S.: The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci. 7: 2203-2213, 1987.
9. GAO, X.-M. AND CHUANG, D.-M.: Carbamazepine-induced neurotoxicity and its prevention by Nmda in cultured cerebellar granule cells. Neurosci Lett. 135: 159-162, 1992a.
10. GAO, X.-M. AND CHUANG, D.-M.: Carbamazepine-induced neurotoxicity in cultured cerebellar granule cells: Evidence for an interaction with NMDA glutamate receptors. Soc. Neurosci. Abstr. 18: 441, 1992b.
11. GRANT, K. A., SNELL, L. D., ROGAWSKI, M. A., THURKAUF, A. AND TABAKOFF, B.: Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260: 1017-1022, 1992.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem 260: 3440-3450, 1985.
13. 2+ in cultured rat hippocampal neurons. Neurosci. Lett. 141: 30-34, 1992.
14. JONES, S. M. AND ROGAWSKI, M A.: The anticonvulsant (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) selectively blocks NMDA-activated current in cultured rat hippocampal neurones: Kinetic analysis and comparison with dizocilpine. Mol. Neuropharmacol. 2: 303-310, 1992.
15. LAMPE, H. AND BIGALKE, H.: Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport 1: 8-10, 1990.
16. LANCASTER, J. M. AND DAVIES, J. A.: Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 mice. Experientia 48: 751-753, 1992.
17. LEPPIK, I. E.: Carbamazepine. In Comprehensive Epileptology, ed. by M. Dam and L. Gram, pp. 525-535, Raven Press, New York, 1991.
18. MARANGOS, P. J., POST, R. M., PATEL, M., ZANDER, K., PARMA, A. AND WEISS, S.: Specific and potent interactions of carbamazepine with brain adenosine receptors. Eur. J. Pharmacol 93: 173-182, 1983.
19. MORIYOSHI, K., MASU, M., ISHII, T., SHIGEMOTO, R., MIZUNO, N. AND NAKANISHI, S.: Molecular cloning and characterization of the rat Nmda receptor. Nature 354: 31-37, 1991.
20. OLPE, H., KOLB, C. N., HAUSDORF, A. AND HAAS, H. L.: 4-Aminopyridine and barium chloride attenuate the antiepileptic effect of carbamazepine in hippocampal slices. Experientia 47: 254-257, 1991.
21. PARKS, T. N., ARTMAN, L. D., ALASTI, N AND NEMETH, E F.: Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells. Brain Res. 552: 13-22, 1991.
22. POST, R., WEISS, S. R. B. AND CHUANG, D.-M. Mechanisms of action of carbamazepine in seizure and affective disorders. In Anitconvulsants in Psychiatry, ed. by R. T. Joffe and J. R. Calabreese, pp. 43-92, Marcel Dekker, New York, 1994.
23. POST, R. M., LEVERICH, G., ROSOFF, A. S. AND ALTSHULER, L. L.: Carbamazepine prophylaxis in refractory affective disorders. A focus on long-term followup. J. Clin. Psychopharmacol. 10: 318-327, 1990.
24. POST, R M., WEISS, S. R. B. AND CHUANG, D.-M.: Mechanisms of action of antidepressants in affective disorders: comparisons with lithium. J. Clin. Psychopharmacol. 12: 23S-35S, 1992.
25. RANDALL, A. D., WENDLAND, B., SCHWEIZER, F., MILJANICH, G., ADAMS, M. E. AND TSIEN, R. W.: Five pharmacologically distinct high voltage activated calcium channels in cerebellar granule cells. Soc. Neurosci. Abstr. 19: 1478, 1993.
26. +-induced depolarization and NMDA exposure. J. Neurochem. 64: 558-565, 1995.
27. REYNOLDS, I. J. AND MILLER, R. J. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br. J. Pharmacol. 95: 95-102, 1988.
28. RHO, J. M., DONEVAN, S. D. AND ROGAWSKI, M A.: Mechanism of action of the anticonvulsant felbamate: opposing effect on N-methyl-D-aspartate and γ-aminobutyric acidA receptors. Ann. Neurol. 35: 229-234, 1994.
29. ROGAWSKI, M. A.: Therapeutic potentail of excitatory amino acid antagonists: channel blockers and 2,3 benzodiazepines. Trends Pharmacol Sci. 14: 325-331, 1993.
30. ROGAWSKI, M. A. AND PORTER, R. J.: Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharm. Rev. 42: 223-286, 1990.
31. SCHIRRMACHER, K., MAYER, A., WALDEN, J., DUSING, R. AND BINGMANN, D.: Effects of carbamazepine on action potentials and calcium currents in rat spinal ganglion cells in vitro. Neuropsychobiology 27: 176-179, 1993.
32. SERNAGOR, E., KUHN, D., VYKLICKY, L. J. AND MAYER, M. L.: Open channel block of Nmda receptor responses evoked by tricyclic antidepressants. Neuron 2: 1221-1227, 1989.
33. WAMIL, A. W. AND MCLEAN, M. J.: Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons J. Pharmacol. Exp. Ther. 267: 218-227, 1993.
34. WATANABE, M., MISHINA, M. AND INOUE, Y.: Distinct spatiotemporal expressions of five Nmda receptor channel subunit mRNAs in the cerebellum. J. Comp. Neurol. 343: 513-519, 1994.
35. 2+ channels in supporting hippocampal synaptic transmission. Science 264: 107-111, 1994.
36. 3H]batrachotoxin A 20-a-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol. 22: 627-635, 1982.
37. ZONA, C., T. ANCREDI, V., PALMA, E., PIRRONE, G. C. AND AVOLI, M : Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can. J. Physiol Pharmacol. 68: 545-547, 1990.